Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Feb 21:2022:6328807.
doi: 10.1155/2022/6328807. eCollection 2022.

Effects of Low-Dose Aspirin Combined with Vitamin E on the Incidence of Intrauterine Growth Restriction and Hemorheological Indexes of Pregnant Women in Patients with Gestational Hypertension

Affiliations
Randomized Controlled Trial

Effects of Low-Dose Aspirin Combined with Vitamin E on the Incidence of Intrauterine Growth Restriction and Hemorheological Indexes of Pregnant Women in Patients with Gestational Hypertension

Tengfei Shan et al. Comput Math Methods Med. .

Retraction in

Abstract

Objective: To investigate the effect of low-dose aspirin combined with vitamin E on the incidence of intrauterine growth restriction and hemorheological indexes of pregnant women in patients with gestational hypertension.

Method: 134 elderly patients with chronic urticaria treated in our hospital from November 2017 to November 2020 were studied. According to the treatment methods, they were randomly divided into observation and control groups. There were 67 patients in the observation group, aged 20-37 years, with an average of (25.7 ± 2.75) years. There were 67 patients in the control group, aged 21-35 years, with an average of (26.3 ± 3.17) years. No significant difference was observed between the two groups (P > 0.05).

Results: The number of cases with postpartum hemorrhage and intrauterine growth restriction in the observation group was less than that in the control group. The total incidence rate was lower than that in the control group. There were significant differences in the above results (P < 0.05). The number of patients with preterm birth in the observation group was less than that in the control group, but there was no significant difference in the results (P > 0.05). The head circumference, abdominal circumference, biparietal diameter, and femoral length diameter in the control and observation groups increased significantly after treatment (P < 0.05). Compared with the control group, the head circumference, abdominal circumference, biparietal diameter, and femoral diameter in the observation group increased more after treatment, and the results were statistically poor (P < 0.05). The systolic blood pressure, diastolic blood pressure, and mean arterial pressure in the control and observation groups decreased significantly after treatment, and the results were statistically different (P < 0.05). Compared with the control group, the systolic blood pressure, diastolic blood pressure, and mean arterial pressure in the observation group decreased more after treatment. The results were statistically different (P < 0.05). The plasma viscosity levels, whole blood high shear viscosity, and whole blood low shear viscosity in the control and observation groups decreased significantly after treatment, and the results were statistically different (P < 0.05). Compared with the control group, plasma viscosity levels, whole blood high shear viscosity, and whole blood low shear viscosity in the observation group decreased more after treatment, and the results were statistically different (P < 0.05). The control and observation groups' fetal systolic/diastolic pressure and pulsatile index decreased significantly after treatment, and the results were statistically different (P < 0.05). Compared with the control group, the fetal systolic/diastolic blood pressure and pulsatile index in the observation group decreased more after treatment, and the results were statistically poor (P < 0.05).

Conclusion: Low-dose aspirin combined with vitamin E is effective in treating intrauterine growth restriction in patients with gestational hypertension. It can effectively control the blood pressure and blood flow of patients and newborns and improve pregnancy outcomes without increasing the incidence of adverse reactions. It is worthy of clinical promotion.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Similar articles

Cited by

References

    1. Wisner K. Safety bundle for severe hypertension during pregnancy and postpartum. MCN: American Journal of Maternal Child Nursing . 2018;43(3):p. 171. doi: 10.1097/NMC.0000000000000420. - DOI - PubMed
    1. Bernstein P. S., Martin J. N., Barton J. R., et al. Consensus bundle on severe hypertension during pregnancy and the postpartum period. Journal of Obstetric, Gynecologic, and Neonatal Nursing . 2017;46(5):776–787. doi: 10.1016/j.jogn.2017.05.003. - DOI - PubMed
    1. Antwi E., Amoakoh-Coleman M., Vieira D. L., et al. Systematic review of prediction models for gestational hypertension and preeclampsia. PLoS One . 2020;15(4, article e0230955) doi: 10.1371/journal.pone.0230955. - DOI - PMC - PubMed
    1. Braunthal S., Brateanu A. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Medicine . 2019;7:p. 205031211984370. doi: 10.1177/2050312119843700. - DOI - PMC - PubMed
    1. Butalia S., Audibert F., Cote A. M., et al. Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy. The Canadian Journal of Cardiology . 2018;34(5):526–531. doi: 10.1016/j.cjca.2018.02.021. - DOI - PubMed

Publication types

MeSH terms